XML 59 R48.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Feb. 02, 2024
May 31, 2025
Jan. 23, 2024
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]                          
Reverse stock split                   1-for-5 and 1-for-40      
Common stock , per value       $ 0.00001           $ 0.00001   $ 0.00001  
Warrants issued                   0 22,471    
Board of Directors Chairman [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock issued for services, shares             1,174            
Stock issued for services, amount             $ 50,000            
Restricted Stock Units (RSUs) [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Stock issued for services, shares       0   625       2,061 1,089    
Stock issued for services, amount       $ 0   $ 6,000       $ 12,000 $ 20,000    
Stock options [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares granted                   15,704 43,096    
Expiration date         Mar. 31, 2035     Jun. 30, 2035 Jun. 30, 2034 Sep. 30, 2035 Sep. 30, 2034    
Stock options valued     $ 4,106   $ 24,612     $ 24,778 $ 16,625 $ 24,762 $ 16,618    
Risk free interest rate         4.3908%     4.39% 4.40% 4.42% 3.79%    
Volatility         148.00%     161.00% 188.00% 159.00% 184.00%    
Exercise price       $ 4.01 $ 9.90 $ 6.60   $ 3.60 $ 16.50 $ 4.01 $ 6.60    
Options granted         2,524     6,944 1,012 6,236 2,492    
Sales Agreement [Member] | At-the-Market Issuance [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued       26,338   233,473       206,713 305,531    
Proceeds from issuance of common stock       $ 119,637   $ 2,001,897       $ 3,630,677 $ 4,178,453    
Placement agent fees                     55,000    
Sales commissions       $ 2,991   $ 50,047       $ 90,247 $ 104,446    
Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrant exercise price       $ 272.26   $ 272.26       $ 272.26 $ 272.26 $ 272.26 $ 291.05
7 accredited investors [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Proceeds from issuance of common stock                   $ 1,000,000      
Placement agent fees                   $ 100,000      
7 accredited investors [Member] | Private Placement [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Reverse stock split   1-for-30 reverse stock split                      
Number of shares issued 561,793                        
Common stock , per value $ 0.00001                        
Warrant exercise price $ 1.78         53.40         $ 53.40    
7 accredited investors [Member] | Private Placement [Member] | Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued                     18,727    
7 accredited investors [Member] | Private Placement [Member] | Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares issued                     18,727    
Altitude Capital [Member] | Placement Agent Agreement [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Placement agent agreement description                   Company entered into a Placement Agent Agreement with Altitude Capital Group, LLC, as placement agent (“Altitude Capital” or the “Placement Agent”). The Company’s Non-Executive Chairman of the Board owns 10% of Altitude Capital. Pursuant to the Placement Agent Agreement, at closing, Altitude Capital was paid a cash commission equal to 10% of the gross proceeds received by the Company, plus 20% warrant coverage, providing Altitude Capital with the right to purchase 3,745 shares (112,353 prior to the Reverse Stock Split) of Common Stock at $53.40 per share ($1.78 prior to the Reverse Stock Split) through February 2, 2030 (the “Placement Agent Warrants”).      
2022 Plan [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Common stock issuance       108,851           108,851      
Number of shares authorized     35,349   95,721                
Number of shares granted     38,894                    
Expiration date     Jan. 23, 2034                    
Number of stock option vested     38,894                    
Stock options valued     $ 2,461,404                    
2022 Plan [Member] | Stock options [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Number of shares granted     39,594                    
Risk free interest rate                     5.22% 4.40%  
Volatility                     228.00% 188.00%  
Exercise price           $ 63.30         $ 63.30 $ 63.30